Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

Learn what some of the latest research says about the heart health benefits of diabetes drugs like SGLT-2 inhibitors, GLP-1 receptor agonists, and non-steroidal MRAs.
Clinical trial results published by Lilly show that Tirzepatide could potentially be one of the most effective drugs ever developed for weight loss. Experts discuss...
​For the first time, Time in Range was used as the main outcome measured in a clinical trial for a diabetes medication. Read about the study results and implications.
Learn more about how you can participate in this clinical trial from Novo Nordisk, testing whether a new once-weekly insulin injection, when combined with semaglutide,...
The diaTribe team is excited to cover all the latest news in diabetes technology and treatments, attending our first in-person diabetes conference in over two years!...
Metformin is the world’s most common diabetes medication and can improve diabetes management. Research suggests that metformin might lead to weight loss in certain...
The FDA approved Ozempic for a 2.0 mg dose, which was based on clinical trial data showing the higher dose led to a better A1C and to weight loss.
Early trial results found that SGLT-2 inhibitor Jardiance is highly effective at preventing and treating kidney disease in people with or without type 2 diabetes.
Trying to learn how to lower morning blood sugar? Here are the reasons why your glucose levels rise in the morning and how you can keep them in range.
Civica, a nonprofit pharmaceutical company, announced plans to make generic insulin available for $30 per vial or $55 for five prefilled pens, regardless of insurance...
US pharmaceutical companies and insulin manufacturers react to proposed legislation that would cap insulin costs and prevent significant rises in the costs of...
Products claiming to treat or even cure diabetes are everywhere, but do these so-called ‘cures’ really work? Spoiler alert: the answer is usually no. Treatments for...
Vabysmo, a new drug manufactured by Roche, was recently approved by the FDA to treat two common eye diseases. Find out more about this medication and how it might help...
Learn more about this clinical trial by Novo Nordisk, that is testing whether a new medication, when combined with semaglutide (also known as Wegovy), can help people...
If you are a new or existing user of Medtronic's MiniMed pumps, read more about what immediate steps you need to take to avoid serious injuries.
Are you currently taking metformin but not meeting your A1C goals? Join a study looking to compare Rybelsus (oral semaglutide) with other oral diabetes drugs to see how...
​Exercising with diabetes is important, but it does provide some additional challenges. Learn how to navigate being an athlete while managing your diabetes from experts.
As scientific researchers continue to make strides toward a cure for type 1 diabetes, diaTribe sat down with Sean Kramer, the CEO of the Diabetes Research Institute...
The American Diabetes Association released its 2022 Standards of Care, which provides an annual update on practice guidelines. Here's what these new updates mean,...
Lilly’s new basal insulin, Rezvoglar, may provide a cheaper alternative to Lantus. This marks the second approval of a biosimilar long-acting insulin.

Pages